Brian has a broad experience in pharmaceuticals ranging from multinationals to private entrepreneurial companies.
He helped create and grow the niche speciality pharma company Amdipharm which was bought by Cinven in Oct 2012 for £367M, staying in the business to merge Amdipharm and Mercury Pharma into AMCo.
He continues to consult for AMCo while building a portfolio of non-executive and advisory roles with companies that can benefit from his skills in strategy, communication, finance, business development and compliance.
BGF portfolio company: Abbey Pharma
James is Chairman of BGF portfolio company Renal Services.
He has over fifteen years of experience working for private equity backed healthcare companies. James’ focus is on companies with very significant growth potential either organically or through acquisition.
Previously he was CEO of Tunstall Healthcare, a world leading provider of telehealthcare solutions, which he led through two transactions with three different private equity investors, growing sales to £150m from 2.5m customers in 30 countries and 1,200 staff globally. James has extensive experience of working in the UK social healthcare market and internationally.
Previously James worked for Cable & Wireless for over ten years, as well as other technology businesses.
BGF portfolio company: Renal Services